Randomised Trial of Cervical Cerclage With and Without Occlusion for the Prevention of Preterm Birth in Women Suspected for Cervical Insufficiency
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Uterine Cervical Incompetence
- Sponsor
- Niels Jørgen Secher
- Enrollment
- 309
- Locations
- 1
- Primary Endpoint
- Take-home baby rate
- Status
- Terminated
- Last Updated
- 13 years ago
Overview
Brief Summary
The aim of this study was to evaluate the effect of cervical occlusion versus no cervical occlusion in women with cervical cerclages.
Detailed Description
Cervical weakness and ascending infection have long been considered important causes of preterm birth. Cervical occlusion could theoretically be used for the treatment of cervical weakness and to protect the cervix against infection. A cervical cerclage could be placed to increase the cervical resistance, and occlusion of the external os could be performed to retain the cervical mucus plug thereby preventing infection. The aim of this multicentre, stratified, randomised controlled trial was to evaluate the effect of cervical occlusion versus no cervical occlusion in women with prophylactic and therapeutic cervical cerclages.
Investigators
Niels Jørgen Secher
Professor
Hvidovre University Hospital
Eligibility Criteria
Inclusion Criteria
- •The physician in charge considered that a cerclage was indicated.
- •Gestational age between 12 and 27 completed weeks.
- •Previous late mid-trimester miscarriage, or spontaneous preterm labour and delivery before 28 weeks with or without previous cerclages.
- •Previous cerclage because of short cervix.
- •Confirmed gestational age defined as gestational age estimated by ultrasound at less than or equal to 22+0 weeks, and/or certain last menstrual period.
- •Vaginal infection treated before cerclage.
- •Ability to read and understand the relevant national language.
- •Consent obtained in accordance with specifications of the local research ethics committee.
- •18 years or more of age and legally competent.
Exclusion Criteria
- •Demonstrated cervical infection.
- •Obstetrical complications in the current pregnancy.
- •Multiple pregnancies.
- •History of a significant abruptio placenta in a previous pregnancy.
Outcomes
Primary Outcomes
Take-home baby rate
Time Frame: Neonates will be followed for the duration of stay in the neonatal intensive care unit, an expected average of 28 days with a minimum of 0 days up to a maximum of 98 days.
Take-home baby rate was defined as the proportion of living babies discharged from the hospital of all singleton pregnancies.
Secondary Outcomes
- Gestational age at birth(At birth)